BioTelemetry (BEAT) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BioTelemetry, Inc. Reports Third Quarter 2014 Financial Results
October 30, 2014 4:05 PM EDTMALVERN, Pa., Oct. 30, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2014.
Company Highlights
Revenue increased 35% to $43.1 million, which includes 9% organic growth Experienced ninth consecutive quarter of year over year revenue growth Serviced over 135,000 patients in the quarter, doubling the prior year volume Generated positive adjusted EBITDA of $6.0 million Announced the reinstatement of... More


